

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | exogenous drug catabolic process (GO:0042738) | 8.60104409 |
| 2 | drug catabolic process (GO:0042737) | 8.32858274 |
| 3 | omega-hydroxylase P450 pathway (GO:0097267) | 8.10016924 |
| 4 | epoxygenase P450 pathway (GO:0019373) | 7.94574423 |
| 5 | glyoxylate metabolic process (GO:0046487) | 7.57892560 |
| 6 | complement activation, alternative pathway (GO:0006957) | 7.37639601 |
| 7 | regulation of protein activation cascade (GO:2000257) | 6.58191069 |
| 8 | regulation of complement activation (GO:0030449) | 6.22605487 |
| 9 | regulation of fibrinolysis (GO:0051917) | 6.18100347 |
| 10 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.14898435 |
| 11 | L-phenylalanine catabolic process (GO:0006559) | 6.14898435 |
| 12 | oxidative demethylation (GO:0070989) | 5.97918598 |
| 13 | ethanol oxidation (GO:0006069) | 5.83252990 |
| 14 | negative regulation of fibrinolysis (GO:0051918) | 5.75482648 |
| 15 | aromatic amino acid family catabolic process (GO:0009074) | 5.57299172 |
| 16 | drug metabolic process (GO:0017144) | 5.53456773 |
| 17 | serine family amino acid catabolic process (GO:0009071) | 5.52219588 |
| 18 | regulation of triglyceride catabolic process (GO:0010896) | 5.33501638 |
| 19 | L-phenylalanine metabolic process (GO:0006558) | 5.15880164 |
| 20 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.15880164 |
| 21 | protein carboxylation (GO:0018214) | 5.10930002 |
| 22 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.10930002 |
| 23 | indole-containing compound catabolic process (GO:0042436) | 5.06099826 |
| 24 | indolalkylamine catabolic process (GO:0046218) | 5.06099826 |
| 25 | tryptophan catabolic process (GO:0006569) | 5.06099826 |
| 26 | phenylpropanoid metabolic process (GO:0009698) | 4.84347869 |
| 27 | bile acid biosynthetic process (GO:0006699) | 4.82407429 |
| 28 | cellular glucuronidation (GO:0052695) | 4.73877226 |
| 29 | ethanol metabolic process (GO:0006067) | 4.71829961 |
| 30 | blood coagulation, intrinsic pathway (GO:0007597) | 4.65814867 |
| 31 | fibrinolysis (GO:0042730) | 4.65750258 |
| 32 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.63544594 |
| 33 | opsonization (GO:0008228) | 4.56350154 |
| 34 | S-adenosylmethionine metabolic process (GO:0046500) | 4.53920160 |
| 35 | negative regulation of cholesterol transport (GO:0032375) | 4.52405921 |
| 36 | negative regulation of sterol transport (GO:0032372) | 4.52405921 |
| 37 | alkaloid metabolic process (GO:0009820) | 4.46384526 |
| 38 | urea metabolic process (GO:0019627) | 4.45586289 |
| 39 | uronic acid metabolic process (GO:0006063) | 4.43986498 |
| 40 | glucuronate metabolic process (GO:0019585) | 4.43986498 |
| 41 | negative regulation of protein activation cascade (GO:2000258) | 4.43419620 |
| 42 | tryptophan metabolic process (GO:0006568) | 4.37936694 |
| 43 | protein activation cascade (GO:0072376) | 4.36137227 |
| 44 | glycine metabolic process (GO:0006544) | 4.23362714 |
| 45 | complement activation (GO:0006956) | 4.23330041 |
| 46 | imidazole-containing compound metabolic process (GO:0052803) | 4.23252557 |
| 47 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.22731665 |
| 48 | bile acid metabolic process (GO:0008206) | 4.17388595 |
| 49 | acylglycerol homeostasis (GO:0055090) | 4.05285873 |
| 50 | triglyceride homeostasis (GO:0070328) | 4.05285873 |
| 51 | nitrogen cycle metabolic process (GO:0071941) | 4.03401237 |
| 52 | complement activation, classical pathway (GO:0006958) | 3.96945750 |
| 53 | cellular ketone body metabolic process (GO:0046950) | 3.93730568 |
| 54 | regulation of humoral immune response (GO:0002920) | 3.91178655 |
| 55 | bile acid and bile salt transport (GO:0015721) | 3.89783513 |
| 56 | arginine metabolic process (GO:0006525) | 3.81802492 |
| 57 | regulation of plasminogen activation (GO:0010755) | 3.81505906 |
| 58 | tyrosine metabolic process (GO:0006570) | 3.78631917 |
| 59 | acute-phase response (GO:0006953) | 3.77191454 |
| 60 | aromatic amino acid family metabolic process (GO:0009072) | 3.76126198 |
| 61 | cytolysis (GO:0019835) | 3.73549559 |
| 62 | negative regulation of complement activation (GO:0045916) | 3.71382744 |
| 63 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.69998200 |
| 64 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.69998200 |
| 65 | alpha-amino acid catabolic process (GO:1901606) | 3.63044141 |
| 66 | indolalkylamine metabolic process (GO:0006586) | 3.60614780 |
| 67 | coenzyme catabolic process (GO:0009109) | 3.58329272 |
| 68 | nucleobase catabolic process (GO:0046113) | 3.57376116 |
| 69 | negative regulation of hemostasis (GO:1900047) | 3.57144970 |
| 70 | negative regulation of blood coagulation (GO:0030195) | 3.57144970 |
| 71 | amino-acid betaine metabolic process (GO:0006577) | 3.56961778 |
| 72 | high-density lipoprotein particle remodeling (GO:0034375) | 3.54243293 |
| 73 | urea cycle (GO:0000050) | 3.52395444 |
| 74 | protein-lipid complex remodeling (GO:0034368) | 3.52156147 |
| 75 | macromolecular complex remodeling (GO:0034367) | 3.52156147 |
| 76 | plasma lipoprotein particle remodeling (GO:0034369) | 3.52156147 |
| 77 | arginine catabolic process (GO:0006527) | 3.48625725 |
| 78 | phospholipid efflux (GO:0033700) | 3.48395116 |
| 79 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.47230208 |
| 80 | kynurenine metabolic process (GO:0070189) | 3.44536039 |
| 81 | ketone body metabolic process (GO:1902224) | 3.40746578 |
| 82 | amine catabolic process (GO:0009310) | 3.35258867 |
| 83 | cellular biogenic amine catabolic process (GO:0042402) | 3.35258867 |
| 84 | serine family amino acid metabolic process (GO:0009069) | 3.34502765 |
| 85 | reverse cholesterol transport (GO:0043691) | 3.32962426 |
| 86 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.32292098 |
| 87 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.32292098 |
| 88 | flavonoid metabolic process (GO:0009812) | 3.30976503 |
| 89 | cholesterol efflux (GO:0033344) | 3.28756009 |
| 90 | intestinal cholesterol absorption (GO:0030299) | 3.23623198 |
| 91 | negative regulation of lipase activity (GO:0060192) | 3.22426078 |
| 92 | heme transport (GO:0015886) | 3.21503376 |
| 93 | sodium-independent organic anion transport (GO:0043252) | 3.21315667 |
| 94 | glutamate metabolic process (GO:0006536) | 3.18882804 |
| 95 | positive regulation of blood coagulation (GO:0030194) | 3.18152089 |
| 96 | positive regulation of hemostasis (GO:1900048) | 3.18152089 |
| 97 | negative regulation of wound healing (GO:0061045) | 3.17396712 |
| 98 | negative regulation of coagulation (GO:0050819) | 3.08802035 |
| 99 | xenobiotic catabolic process (GO:0042178) | 3.06421796 |
| 100 | peptidyl-glutamic acid modification (GO:0018200) | 3.04215059 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.65751146 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.47682158 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.94718117 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.93038920 |
| 5 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.66126800 |
| 6 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.29400585 |
| 7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.20324030 |
| 8 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.15823247 |
| 9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.08888817 |
| 10 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.08851114 |
| 11 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.06594617 |
| 12 | VDR_22108803_ChIP-Seq_LS180_Human | 2.00473004 |
| 13 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.99281707 |
| 14 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.96329559 |
| 15 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.92694886 |
| 16 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.83833218 |
| 17 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.79565264 |
| 18 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.77144449 |
| 19 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.74727333 |
| 20 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.74258319 |
| 21 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.73997276 |
| 22 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.70507324 |
| 23 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.68864489 |
| 24 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.61483676 |
| 25 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.60778676 |
| 26 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.59357717 |
| 27 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.58874563 |
| 28 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.58874563 |
| 29 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.55857509 |
| 30 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.55503261 |
| 31 | P300_19829295_ChIP-Seq_ESCs_Human | 1.54924781 |
| 32 | STAT3_23295773_ChIP-Seq_U87_Human | 1.53509929 |
| 33 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.52967226 |
| 34 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.51612824 |
| 35 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.51612824 |
| 36 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.48399468 |
| 37 | FUS_26573619_Chip-Seq_HEK293_Human | 1.47767194 |
| 38 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.45686496 |
| 39 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.39279302 |
| 40 | TCF4_23295773_ChIP-Seq_U87_Human | 1.38273914 |
| 41 | TP53_16413492_ChIP-PET_HCT116_Human | 1.37453398 |
| 42 | AR_25329375_ChIP-Seq_VCAP_Human | 1.37118762 |
| 43 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.36997850 |
| 44 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.35400762 |
| 45 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.33753697 |
| 46 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.32458121 |
| 47 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.30566426 |
| 48 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.28164802 |
| 49 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.28123591 |
| 50 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.27783904 |
| 51 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.27528437 |
| 52 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.27401236 |
| 53 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.27289832 |
| 54 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.26436340 |
| 55 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.24987208 |
| 56 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.23722236 |
| 57 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.21728371 |
| 58 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.21448332 |
| 59 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.21005642 |
| 60 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.20364294 |
| 61 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.18340173 |
| 62 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.16289030 |
| 63 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.14585202 |
| 64 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.13233792 |
| 65 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.13007504 |
| 66 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.12751537 |
| 67 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.11615382 |
| 68 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.10146149 |
| 69 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.09773986 |
| 70 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.09769895 |
| 71 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.09010659 |
| 72 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.08909628 |
| 73 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.08777954 |
| 74 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.08701194 |
| 75 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.08315030 |
| 76 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.08315030 |
| 77 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.07056981 |
| 78 | TBL1_22424771_ChIP-Seq_293T_Human | 1.06738329 |
| 79 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.06149726 |
| 80 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.05889221 |
| 81 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.05861638 |
| 82 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.05739985 |
| 83 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.05563638 |
| 84 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.04179767 |
| 85 | EWS_26573619_Chip-Seq_HEK293_Human | 1.02719050 |
| 86 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.02140989 |
| 87 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.02088599 |
| 88 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.01811657 |
| 89 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.01160944 |
| 90 | NFYA_21822215_ChIP-Seq_K562_Human | 1.00209309 |
| 91 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.98644125 |
| 92 | NFYB_21822215_ChIP-Seq_K562_Human | 0.98382023 |
| 93 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.98230770 |
| 94 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.97678153 |
| 95 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.96983247 |
| 96 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.96782258 |
| 97 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.96016673 |
| 98 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.95769539 |
| 99 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.95205062 |
| 100 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.95109084 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.86702703 |
| 2 | MP0005360_urolithiasis | 5.08070962 |
| 3 | MP0003195_calcinosis | 4.95864682 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.84601486 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.72725885 |
| 6 | MP0002138_abnormal_hepatobiliary_system | 4.03345097 |
| 7 | MP0005365_abnormal_bile_salt | 3.79474140 |
| 8 | MP0003252_abnormal_bile_duct | 3.37777951 |
| 9 | MP0002876_abnormal_thyroid_physiology | 2.74181561 |
| 10 | MP0010329_abnormal_lipoprotein_level | 2.25534006 |
| 11 | MP0003880_abnormal_central_pattern | 2.14062593 |
| 12 | MP0001666_abnormal_nutrient_absorption | 2.11563217 |
| 13 | MP0009697_abnormal_copulation | 1.96590035 |
| 14 | MP0003787_abnormal_imprinting | 1.95759787 |
| 15 | MP0003868_abnormal_feces_composition | 1.91111603 |
| 16 | MP0005332_abnormal_amino_acid | 1.85047188 |
| 17 | MP0001764_abnormal_homeostasis | 1.69790273 |
| 18 | MP0006292_abnormal_olfactory_placode | 1.69548830 |
| 19 | MP0004142_abnormal_muscle_tone | 1.63217924 |
| 20 | MP0003122_maternal_imprinting | 1.56821739 |
| 21 | MP0009764_decreased_sensitivity_to | 1.53333689 |
| 22 | MP0006276_abnormal_autonomic_nervous | 1.49704885 |
| 23 | MP0005551_abnormal_eye_electrophysiolog | 1.45711510 |
| 24 | MP0002118_abnormal_lipid_homeostasis | 1.35295488 |
| 25 | MP0009745_abnormal_behavioral_response | 1.28830589 |
| 26 | MP0008877_abnormal_DNA_methylation | 1.21893755 |
| 27 | MP0000609_abnormal_liver_physiology | 1.20380626 |
| 28 | MP0003121_genomic_imprinting | 1.18620117 |
| 29 | MP0008872_abnormal_physiological_respon | 1.16867857 |
| 30 | MP0001440_abnormal_grooming_behavior | 1.14856322 |
| 31 | MP0005423_abnormal_somatic_nervous | 1.13495671 |
| 32 | MP0002102_abnormal_ear_morphology | 1.11635112 |
| 33 | MP0002272_abnormal_nervous_system | 1.10804702 |
| 34 | MP0001986_abnormal_taste_sensitivity | 1.05839446 |
| 35 | MP0001486_abnormal_startle_reflex | 1.05455753 |
| 36 | MP0010368_abnormal_lymphatic_system | 1.04013438 |
| 37 | MP0009046_muscle_twitch | 1.02667185 |
| 38 | MP0005646_abnormal_pituitary_gland | 1.01425522 |
| 39 | MP0002928_abnormal_bile_duct | 1.01201682 |
| 40 | MP0003646_muscle_fatigue | 0.97022021 |
| 41 | MP0009840_abnormal_foam_cell | 0.95970028 |
| 42 | MP0003191_abnormal_cellular_cholesterol | 0.94764093 |
| 43 | MP0001968_abnormal_touch/_nociception | 0.94358151 |
| 44 | MP0004130_abnormal_muscle_cell | 0.93945685 |
| 45 | MP0004742_abnormal_vestibular_system | 0.93349512 |
| 46 | MP0003656_abnormal_erythrocyte_physiolo | 0.91256525 |
| 47 | MP0003879_abnormal_hair_cell | 0.89709368 |
| 48 | MP0000569_abnormal_digit_pigmentation | 0.88716614 |
| 49 | MP0002168_other_aberrant_phenotype | 0.88707413 |
| 50 | MP0003878_abnormal_ear_physiology | 0.87859939 |
| 51 | MP0005377_hearing/vestibular/ear_phenot | 0.87859939 |
| 52 | MP0002638_abnormal_pupillary_reflex | 0.85993928 |
| 53 | MP0002971_abnormal_brown_adipose | 0.85570669 |
| 54 | MP0002132_abnormal_respiratory_system | 0.84471883 |
| 55 | MP0002064_seizures | 0.83911124 |
| 56 | MP0003635_abnormal_synaptic_transmissio | 0.81878123 |
| 57 | MP0004924_abnormal_behavior | 0.81559655 |
| 58 | MP0005386_behavior/neurological_phenoty | 0.81559655 |
| 59 | MP0003633_abnormal_nervous_system | 0.79140295 |
| 60 | MP0001501_abnormal_sleep_pattern | 0.78997633 |
| 61 | MP0005376_homeostasis/metabolism_phenot | 0.74660653 |
| 62 | MP0009115_abnormal_fat_cell | 0.74621215 |
| 63 | MP0009642_abnormal_blood_homeostasis | 0.74520289 |
| 64 | MP0004019_abnormal_vitamin_homeostasis | 0.74416178 |
| 65 | MP0002063_abnormal_learning/memory/cond | 0.74310799 |
| 66 | MP0000778_abnormal_nervous_system | 0.72383652 |
| 67 | MP0002067_abnormal_sensory_capabilities | 0.72261250 |
| 68 | MP0009053_abnormal_anal_canal | 0.71978991 |
| 69 | MP0002557_abnormal_social/conspecific_i | 0.71297777 |
| 70 | MP0002078_abnormal_glucose_homeostasis | 0.71089643 |
| 71 | MP0001485_abnormal_pinna_reflex | 0.70643248 |
| 72 | MP0000955_abnormal_spinal_cord | 0.70613330 |
| 73 | MP0003011_delayed_dark_adaptation | 0.70095198 |
| 74 | MP0004859_abnormal_synaptic_plasticity | 0.69513232 |
| 75 | MP0005395_other_phenotype | 0.69109001 |
| 76 | MP0004484_altered_response_of | 0.69055171 |
| 77 | MP0000230_abnormal_systemic_arterial | 0.68803836 |
| 78 | MP0000631_abnormal_neuroendocrine_gland | 0.68341018 |
| 79 | MP0009643_abnormal_urine_homeostasis | 0.67522113 |
| 80 | MP0002572_abnormal_emotion/affect_behav | 0.65502987 |
| 81 | MP0005334_abnormal_fat_pad | 0.65500973 |
| 82 | MP0005195_abnormal_posterior_eye | 0.65377242 |
| 83 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.65219708 |
| 84 | MP0002282_abnormal_trachea_morphology | 0.64713899 |
| 85 | MP0004885_abnormal_endolymph | 0.63766807 |
| 86 | MP0001502_abnormal_circadian_rhythm | 0.62691169 |
| 87 | MP0005253_abnormal_eye_physiology | 0.62648222 |
| 88 | MP0005319_abnormal_enzyme/_coenzyme | 0.62623288 |
| 89 | MP0005535_abnormal_body_temperature | 0.61002343 |
| 90 | MP0005670_abnormal_white_adipose | 0.60945431 |
| 91 | MP0005266_abnormal_metabolism | 0.59661188 |
| 92 | MP0002653_abnormal_ependyma_morphology | 0.58993954 |
| 93 | MP0003638_abnormal_response/metabolism_ | 0.58828502 |
| 94 | MP0000427_abnormal_hair_cycle | 0.58342690 |
| 95 | MP0003631_nervous_system_phenotype | 0.58012582 |
| 96 | MP0004145_abnormal_muscle_electrophysio | 0.57651304 |
| 97 | MP0004133_heterotaxia | 0.56615475 |
| 98 | MP0005448_abnormal_energy_balance | 0.56248863 |
| 99 | MP0003123_paternal_imprinting | 0.55533902 |
| 100 | MP0000639_abnormal_adrenal_gland | 0.55501403 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Complement deficiency (HP:0004431) | 7.55011262 |
| 2 | Prolonged partial thromboplastin time (HP:0003645) | 6.78274551 |
| 3 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.76171881 |
| 4 | Deep venous thrombosis (HP:0002625) | 6.39732773 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.11625118 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 5.93000788 |
| 7 | Abnormality of complement system (HP:0005339) | 5.55508813 |
| 8 | Conjugated hyperbilirubinemia (HP:0002908) | 5.53624745 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.40753112 |
| 10 | Joint hemorrhage (HP:0005261) | 4.60588770 |
| 11 | Systemic lupus erythematosus (HP:0002725) | 4.22008692 |
| 12 | Spontaneous abortion (HP:0005268) | 3.97242285 |
| 13 | Chronic hepatic failure (HP:0100626) | 3.83370965 |
| 14 | Intrahepatic cholestasis (HP:0001406) | 3.71914596 |
| 15 | Xanthomatosis (HP:0000991) | 3.71612528 |
| 16 | Glomerulonephritis (HP:0000099) | 3.62917819 |
| 17 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.59633056 |
| 18 | Fair hair (HP:0002286) | 3.42808939 |
| 19 | Hypolipoproteinemia (HP:0010981) | 3.37582282 |
| 20 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.32082186 |
| 21 | Hyperglycinemia (HP:0002154) | 3.28647789 |
| 22 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.11870244 |
| 23 | Abnormality of the intrinsic pathway (HP:0010989) | 3.01570728 |
| 24 | Abnormality of the common coagulation pathway (HP:0010990) | 2.99158443 |
| 25 | Epidermoid cyst (HP:0200040) | 2.98110640 |
| 26 | Abnormality of methionine metabolism (HP:0010901) | 2.87966065 |
| 27 | Delayed CNS myelination (HP:0002188) | 2.82874301 |
| 28 | Thyroid-stimulating hormone excess (HP:0002925) | 2.82041592 |
| 29 | Nephritis (HP:0000123) | 2.73691578 |
| 30 | Neonatal hypoglycemia (HP:0001998) | 2.72875158 |
| 31 | Abnormality of glycine metabolism (HP:0010895) | 2.69930890 |
| 32 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.69930890 |
| 33 | Osteomalacia (HP:0002749) | 2.65030712 |
| 34 | Bile duct proliferation (HP:0001408) | 2.56445399 |
| 35 | Abnormal biliary tract physiology (HP:0012439) | 2.56445399 |
| 36 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.55014414 |
| 37 | Hypoalphalipoproteinemia (HP:0003233) | 2.52757069 |
| 38 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.48363866 |
| 39 | Generalized hypopigmentation of hair (HP:0011358) | 2.44188492 |
| 40 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.43156937 |
| 41 | Arthropathy (HP:0003040) | 2.39478874 |
| 42 | Hyperglycinuria (HP:0003108) | 2.38221516 |
| 43 | Gingival bleeding (HP:0000225) | 2.36057327 |
| 44 | Ketosis (HP:0001946) | 2.33180340 |
| 45 | Abnormality of serum amino acid levels (HP:0003112) | 2.29173971 |
| 46 | Hypochromic microcytic anemia (HP:0004840) | 2.21761023 |
| 47 | Hyperventilation (HP:0002883) | 2.18791842 |
| 48 | Nephronophthisis (HP:0000090) | 2.18097691 |
| 49 | Medial flaring of the eyebrow (HP:0010747) | 2.12276721 |
| 50 | Pancreatic fibrosis (HP:0100732) | 2.12210988 |
| 51 | Generalized aminoaciduria (HP:0002909) | 2.07705323 |
| 52 | Status epilepticus (HP:0002133) | 2.05855127 |
| 53 | True hermaphroditism (HP:0010459) | 2.05435317 |
| 54 | Pulmonary embolism (HP:0002204) | 2.03041560 |
| 55 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.00964616 |
| 56 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.00311826 |
| 57 | Gaze-evoked nystagmus (HP:0000640) | 1.99157907 |
| 58 | Poikilocytosis (HP:0004447) | 1.97837963 |
| 59 | Mitral stenosis (HP:0001718) | 1.97591692 |
| 60 | Dyskinesia (HP:0100660) | 1.97391427 |
| 61 | Thrombophlebitis (HP:0004418) | 1.96945839 |
| 62 | Pigmentary retinal degeneration (HP:0001146) | 1.94977386 |
| 63 | Abnormality of midbrain morphology (HP:0002418) | 1.94665762 |
| 64 | Molar tooth sign on MRI (HP:0002419) | 1.94665762 |
| 65 | Abnormality of nucleobase metabolism (HP:0010932) | 1.93415346 |
| 66 | Fat malabsorption (HP:0002630) | 1.91506533 |
| 67 | Focal seizures (HP:0007359) | 1.91358976 |
| 68 | Epileptic encephalopathy (HP:0200134) | 1.91041943 |
| 69 | Hyperammonemia (HP:0001987) | 1.88943423 |
| 70 | Abnormality of the renal cortex (HP:0011035) | 1.87258424 |
| 71 | Hyperbilirubinemia (HP:0002904) | 1.86705686 |
| 72 | Gait imbalance (HP:0002141) | 1.86523045 |
| 73 | Abnormality of alanine metabolism (HP:0010916) | 1.86325329 |
| 74 | Hyperalaninemia (HP:0003348) | 1.86325329 |
| 75 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.86325329 |
| 76 | Abnormality of the renal medulla (HP:0100957) | 1.84744151 |
| 77 | Febrile seizures (HP:0002373) | 1.81738943 |
| 78 | Reduced antithrombin III activity (HP:0001976) | 1.80546508 |
| 79 | Pancreatic cysts (HP:0001737) | 1.80494531 |
| 80 | Enlarged kidneys (HP:0000105) | 1.78543639 |
| 81 | Hypercholesterolemia (HP:0003124) | 1.78161162 |
| 82 | Type II lissencephaly (HP:0007260) | 1.75567263 |
| 83 | Polyphagia (HP:0002591) | 1.71796355 |
| 84 | Congenital primary aphakia (HP:0007707) | 1.71716423 |
| 85 | Hypothermia (HP:0002045) | 1.70494773 |
| 86 | Abnormality of vitamin metabolism (HP:0100508) | 1.69339726 |
| 87 | Absent/shortened dynein arms (HP:0200106) | 1.68188040 |
| 88 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.68188040 |
| 89 | Metabolic acidosis (HP:0001942) | 1.65728937 |
| 90 | Progressive cerebellar ataxia (HP:0002073) | 1.65661309 |
| 91 | Poor coordination (HP:0002370) | 1.65383990 |
| 92 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.64082905 |
| 93 | Nephrogenic diabetes insipidus (HP:0009806) | 1.63440079 |
| 94 | Broad-based gait (HP:0002136) | 1.62352623 |
| 95 | Intestinal atresia (HP:0011100) | 1.60639094 |
| 96 | Drooling (HP:0002307) | 1.60323928 |
| 97 | Thyroiditis (HP:0100646) | 1.60001787 |
| 98 | Rickets (HP:0002748) | 1.59841684 |
| 99 | Blue irides (HP:0000635) | 1.56457963 |
| 100 | Congenital stationary night blindness (HP:0007642) | 1.56312098 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 4.44005703 |
| 2 | PINK1 | 3.01350642 |
| 3 | ADRBK2 | 2.61797788 |
| 4 | MAP4K2 | 2.47968930 |
| 5 | TAOK3 | 2.38889864 |
| 6 | MAP3K4 | 2.21804274 |
| 7 | TRIM28 | 2.21150208 |
| 8 | MAP2K7 | 2.09661037 |
| 9 | CAMKK2 | 2.02928319 |
| 10 | NTRK3 | 1.93717497 |
| 11 | SGK2 | 1.82036271 |
| 12 | CASK | 1.64058271 |
| 13 | SGK494 | 1.62042502 |
| 14 | SGK223 | 1.62042502 |
| 15 | WNK3 | 1.61946302 |
| 16 | MAPK13 | 1.51247018 |
| 17 | CAMK1D | 1.50521540 |
| 18 | MARK1 | 1.49605007 |
| 19 | PIK3CA | 1.48220467 |
| 20 | SIK2 | 1.45396310 |
| 21 | EPHA4 | 1.43110680 |
| 22 | MARK3 | 1.41309613 |
| 23 | PAK3 | 1.41242053 |
| 24 | BLK | 1.40349517 |
| 25 | STK16 | 1.38774429 |
| 26 | CAMK1G | 1.36826866 |
| 27 | MAP2K4 | 1.36130449 |
| 28 | GRK1 | 1.33331367 |
| 29 | IRAK1 | 1.30710271 |
| 30 | AKT3 | 1.26960544 |
| 31 | BMPR1B | 1.21845212 |
| 32 | DAPK2 | 1.17415206 |
| 33 | DYRK3 | 1.15337001 |
| 34 | PRKCG | 1.14188974 |
| 35 | NUAK1 | 1.10056437 |
| 36 | SGK3 | 1.08932378 |
| 37 | ACVR1B | 1.05437198 |
| 38 | DYRK2 | 1.04591428 |
| 39 | MAP3K9 | 1.04188906 |
| 40 | CAMK4 | 1.01788435 |
| 41 | TNK2 | 1.01691239 |
| 42 | MKNK2 | 0.97511218 |
| 43 | PIK3CG | 0.93050487 |
| 44 | CAMK1 | 0.90793697 |
| 45 | OBSCN | 0.90631401 |
| 46 | NTRK2 | 0.89000413 |
| 47 | IRAK2 | 0.87517766 |
| 48 | ERBB2 | 0.87517705 |
| 49 | MAP3K6 | 0.85464069 |
| 50 | BCR | 0.84770909 |
| 51 | RPS6KA4 | 0.78582798 |
| 52 | PRKCQ | 0.77896555 |
| 53 | PNCK | 0.76762342 |
| 54 | CAMKK1 | 0.76564326 |
| 55 | TNIK | 0.74511216 |
| 56 | TXK | 0.74259103 |
| 57 | LATS1 | 0.72311693 |
| 58 | PRKAA2 | 0.67291679 |
| 59 | PRKCE | 0.66421584 |
| 60 | DYRK1A | 0.65990303 |
| 61 | PRKAA1 | 0.65803282 |
| 62 | PRKACG | 0.65194706 |
| 63 | PRKG1 | 0.64605503 |
| 64 | SGK1 | 0.64246166 |
| 65 | STK11 | 0.63890791 |
| 66 | PKN2 | 0.63508612 |
| 67 | INSRR | 0.62702597 |
| 68 | SIK3 | 0.62119471 |
| 69 | TEC | 0.62034296 |
| 70 | NLK | 0.61896208 |
| 71 | PDK1 | 0.60118961 |
| 72 | IRAK4 | 0.60060585 |
| 73 | PRKACA | 0.59431662 |
| 74 | ITK | 0.58086335 |
| 75 | ADRBK1 | 0.56289377 |
| 76 | PRKCZ | 0.56286968 |
| 77 | SYK | 0.54475394 |
| 78 | BTK | 0.54051669 |
| 79 | MAP3K7 | 0.53998581 |
| 80 | IKBKE | 0.53518702 |
| 81 | MUSK | 0.53180912 |
| 82 | FES | 0.52557344 |
| 83 | CSNK1G2 | 0.52386868 |
| 84 | FGFR2 | 0.52356931 |
| 85 | MAPK12 | 0.51420103 |
| 86 | CDK19 | 0.51298512 |
| 87 | BCKDK | 0.50452293 |
| 88 | PKN1 | 0.50004133 |
| 89 | RPS6KA6 | 0.46245870 |
| 90 | MINK1 | 0.46131310 |
| 91 | ZAK | 0.45725102 |
| 92 | PTK2B | 0.45084056 |
| 93 | CSNK1G1 | 0.41495020 |
| 94 | BRSK2 | 0.39662816 |
| 95 | RPS6KA3 | 0.39186190 |
| 96 | FGFR3 | 0.38999931 |
| 97 | CDK3 | 0.38845953 |
| 98 | RPS6KA5 | 0.37921461 |
| 99 | EPHA3 | 0.37832705 |
| 100 | RPS6KA2 | 0.37649102 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Caffeine metabolism_Homo sapiens_hsa00232 | 4.46302537 |
| 2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.68110221 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.62194889 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.60176320 |
| 5 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.42505307 |
| 6 | Retinol metabolism_Homo sapiens_hsa00830 | 3.33835835 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.24668104 |
| 8 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.94512656 |
| 9 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.69470350 |
| 10 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.67484012 |
| 11 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.64988430 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.54107159 |
| 13 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.53103559 |
| 14 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.52403535 |
| 15 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.28972498 |
| 16 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.20975385 |
| 17 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.16669621 |
| 18 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.00383273 |
| 19 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.96030643 |
| 20 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.93363641 |
| 21 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.93081796 |
| 22 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.88337122 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.84766979 |
| 24 | Bile secretion_Homo sapiens_hsa04976 | 1.55568466 |
| 25 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.52591830 |
| 26 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.51211009 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.45891485 |
| 28 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.44527528 |
| 29 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.40322618 |
| 30 | Peroxisome_Homo sapiens_hsa04146 | 1.35245892 |
| 31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.32989796 |
| 32 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.22913809 |
| 33 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.20659907 |
| 34 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.18657133 |
| 35 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.12627757 |
| 36 | ABC transporters_Homo sapiens_hsa02010 | 1.12485654 |
| 37 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.10665058 |
| 38 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.04106954 |
| 39 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.99957925 |
| 40 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.99235675 |
| 41 | Prion diseases_Homo sapiens_hsa05020 | 0.91815356 |
| 42 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.91356292 |
| 43 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.86968062 |
| 44 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.76748035 |
| 45 | Sulfur relay system_Homo sapiens_hsa04122 | 0.72276801 |
| 46 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.65971422 |
| 47 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.59340334 |
| 48 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.58787103 |
| 49 | Nicotine addiction_Homo sapiens_hsa05033 | 0.58015026 |
| 50 | Lysine degradation_Homo sapiens_hsa00310 | 0.56215753 |
| 51 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.55635303 |
| 52 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.54194611 |
| 53 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.54136128 |
| 54 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.51217059 |
| 55 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.50844766 |
| 56 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.41511095 |
| 57 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.41177610 |
| 58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.38409996 |
| 59 | Circadian rhythm_Homo sapiens_hsa04710 | 0.37826372 |
| 60 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.35139163 |
| 61 | Morphine addiction_Homo sapiens_hsa05032 | 0.33784066 |
| 62 | Metabolic pathways_Homo sapiens_hsa01100 | 0.33714116 |
| 63 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.33623434 |
| 64 | Cocaine addiction_Homo sapiens_hsa05030 | 0.33261948 |
| 65 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.33134956 |
| 66 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.32864332 |
| 67 | Phototransduction_Homo sapiens_hsa04744 | 0.31039314 |
| 68 | Insulin resistance_Homo sapiens_hsa04931 | 0.29687147 |
| 69 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.29181452 |
| 70 | Olfactory transduction_Homo sapiens_hsa04740 | 0.27826015 |
| 71 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.27761767 |
| 72 | GABAergic synapse_Homo sapiens_hsa04727 | 0.24822870 |
| 73 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.24571157 |
| 74 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.23905038 |
| 75 | Insulin secretion_Homo sapiens_hsa04911 | 0.23763294 |
| 76 | Taste transduction_Homo sapiens_hsa04742 | 0.20707339 |
| 77 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.20701573 |
| 78 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.18699065 |
| 79 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.18324448 |
| 80 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.18085471 |
| 81 | Circadian entrainment_Homo sapiens_hsa04713 | 0.17036234 |
| 82 | Long-term depression_Homo sapiens_hsa04730 | 0.15865353 |
| 83 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.14556143 |
| 84 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.14339366 |
| 85 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.12126914 |
| 86 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.10458598 |
| 87 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.10181262 |
| 88 | Mineral absorption_Homo sapiens_hsa04978 | 0.08180890 |
| 89 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.07795379 |
| 90 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.07741952 |
| 91 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.07735806 |
| 92 | Pertussis_Homo sapiens_hsa05133 | 0.07309831 |
| 93 | Renin secretion_Homo sapiens_hsa04924 | 0.06619535 |
| 94 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.05729746 |
| 95 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.04725237 |
| 96 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.02954010 |
| 97 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.01409181 |
| 98 | Carbon metabolism_Homo sapiens_hsa01200 | 0.00716680 |
| 99 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.00318260 |
| 100 | Salivary secretion_Homo sapiens_hsa04970 | -0.0029804 |

